CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,092
- in 3 filings, $19K under 10b5-1 plans
Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | O'Neill Gilmore Neil CEO | Grant or award | +86,655 | 86,655 | ||
| 2022-06-02 | O'Neill Gilmore Neil CEO | Grant or award · Stock Option (right to buy) | +950,209 | 950,209 | ||
| 2022-05-09 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −297 | $13.11 | $4K | 66,544 |
| 2022-04-14 | MULLEN JAMES C CEO | Grant or award · Stock Option (right to buy) | +170,989 | 170,989 | ||
| 2022-04-01 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −1,258 | $19.64 | $25K | 66,841 |
| 2022-03-03 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −403 | $17.33 | $7K | 68,386 |
| 2022-03-03 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −767 | $17.33 | $13K | 84,194 |
| 2022-02-10 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Grant or award | +37,593 | 68,789 | ||
| 2022-02-10 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Grant or award · Stock Option (right to buy) | +110,732 | 110,732 | ||
| 2022-02-10 | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | Grant or award | +31,709 | 73,494 | ||
| 2022-02-10 | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (right to buy) | +93,398 | 93,398 | ||
| 2022-02-10 | ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER | Grant or award | +53,499 | 84,961 | ||
| 2022-02-10 | ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +157,580 | 157,580 | ||
| 2022-02-08 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −302 | $17.63 | $5K | 31,196 |
| 2022-01-11 | ROBERTSON MICHELLE Chief Financial Officer | Sale | −1,744 | $25.70 | $45K | 31,462 |
| 2022-01-03 | MULLEN JAMES C CEO | Sale | −18,252 | $26.95 | $492K | 75,898 |
| 2021-12-22 | Eaton Bruce EVP, Chief Business Officer | Grant or award | +3,472 | 31,498 | ||
| 2021-12-22 | Michaels Lisa Anne EVP/Chief Medical Officer | Grant or award | +4,243 | 22,675 | ||
| 2021-12-22 | Shearman Mark S EVP, Chief Scientific Officer | Grant or award | +9,084 | 41,785 | ||
| 2021-12-22 | ROBERTSON MICHELLE Chief Financial Officer | Grant or award | +4,471 | 33,206 |
Page 8 of 15 · 283 trades